NATALIE BOWMAN: Open Payments
NPI 1932957362 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,915 in 80 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $763 · 2025 $1,915
Food & beverage: $1,703Education: $212
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $181 |
| Incyte Corporation | 3 | $151 |
| Celgene Corporation | 5 | $131 |
| Merck Sharp & Dohme LLC | 5 | $125 |
| Janssen Biotech, Inc. | 5 | $108 |
| E.R. Squibb & Sons, L.L.C. | 6 | $106 |
| PFIZER INC. | 5 | $101 |
| ABBVIE INC. | 4 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| GlaxoSmithKline, LLC. | 3 | $70 |
Products named: KEYTRUDA, OPDIVO, EPKINLY, OJJAARA, ENHERTU, OPDUALAG, BESREMI, RYTELO.
Industry payments across TX — which companies pay providers there.
